Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients

Circulation

Volumn 110, Issue 17, 2004, Pages 2601-2608

  Ohuchi, Hideo ^a,b   Takasugi, Hisashi ^a   Ohashi, Hiroyuki ^a   Yamada, Osamu ^a   Watanabe, Ken ^a   Yagihara, Toshikatsu ^a   Echigo, Shigeyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

Fontan procedure; Heart defects; Heart failure; Hormones; Nervous system, autonomic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE; NORADRENALIN;

ADOLESCENT; ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOPULMONARY HEMODYNAMICS; CHILD; CONTROLLED STUDY; FEMALE; FONTAN PROCEDURE; HEART FAILURE; HEART FUNCTION; HEART RATE VARIABILITY; HEART VENTRICLE CONTRACTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; EXERCISE TEST; FEMALE; FONTAN PROCEDURE; HEART; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; MALE; NEUROTRANSMITTER AGENTS; VITAL CAPACITY;

EID: 7544226189     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145545.83564.51     Document Type: Article

References (30)

1. Ohuchi H, Yasuda K, Hasegawa S, et al. Influence of ventricular morphology on aerobic exercise capacity in patients after the Fontan operation. J Am Coll Cardiol. 2001;37:1967-1974.
2. Ohuchi H, Tasato H, Sugiyama H, et al. Responses of plasma norepinephrine and heart rate during exercise in patients after Fontan operation and patients with residual right ventricular outflow tract obstruction after definitive reconstruction. Pediatr Cardiol. 1998;19:408-413.
3. Stewart JM, Seligman KP, Zeballos G, et al. Elevated atrial natriuretic peptide after the Fontan procedure. Circulation. 1987;76(suppl III):III-77-III-82.
4. Driscoll DJ, Danielson GK, Puga FJ, et al. Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol. 1986;7:1087-1094.
5. Ohuchi H, Hasegawa S, Yasuda K, et al. Severely impaired cardiac autonomic nervous activity after the Fontan operation. Circulation. 2001;104:1513-1518.
6. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med. 1984;311:819-823.
7. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with congestive heart failure. Circulation. 2002;105:2392-2397.
8. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflex After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
9. Blichick KC, Fetics B, Djoukeng R, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90:24-28.
10. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with congestive heart failure and preserved exercise tolerance: marker of abnormal cardiopulmonary reflex control and predictor of poor prognosis. Circulation. 2001;103:967-972.
11. Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation. 2003;108:2368-2376.
12. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001;138:505-511.
13. Mori K. Automated measurement of catecholamines in urine, plasma and homogenates by high-performance liquid chromatography with fluorometric detection. J Chromatogr. 1981;218:631-637.
14. Hama N, Nakao K, Mukoyama M, et al. Fundamental and clinical evaluation of "SHINORIAR ANP" human atrial natriuretic peptide IRMA kit. Clin Report. 1991;25:455-462.
15. Kono M, Yamaguchi A, Tsuji T, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku. 1993;13:2-7.
16. Ikeda I, Iinuma K, Takai M, et al. Measurement of plasma renin activity by a simple solid phase radioimmunoassay. J Clin Endocrinol Metab. 1982;54:423-428.
17. Ando K, Hirata Y, Shichiri M, et al. Presence of immunoreactive endothelin in human plasma. FEBS Lett. 1989;245:164-166.
18. Smyth HS, Slight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. Circ Res. 1969;24:109-121.
19. Ohuchi H, Nakajima T, Kawade M, et al. Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol. 1996;17:7-14.
20. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92-99.
21. Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Failure. 2000;6:92-96.
22. Halliwill JR, Minson CT. Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans. J Appl Physiol 2002;93:857-864.
23. Sietsema KE, Cooper DM, Perloff JK, et al. Control of ventilation during exercise in patients with central-to-systemic arterial shunts. J Appl Physiol. 1988;64:234-242.
24. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000;65:357-369.
25. Hokins WE, Hall C. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic heart disease. Circulation. 1997;96:2215-2220.
26. Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995;26:1581-1585.
27. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
28. Makikallio TH, Huikuri HV, Hintze U, et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol. 2001;87:178-182.
29. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079-3084.
30. Driscoll DJ, Offord KP, Feldt RH, et al. Five-to fifteen-year follow-up after Fontan operation. Circulation. 1992;85:496-496.